Inso Biosciences Inc.

Ithaca, NY

UEI
VBDURZTP43R3
CAGE
9HVL4, 84KC0
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
Weill Hall, 237 Tower Rd Rm 410, Ithaca, NY 14853, USA
Website
inso.bio
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Inso Biosciences Inc.

Inso Biosciences Inc. is an early stage biotechnology startup that develops platform technologies for biological sample preparation using patented microfluidic technology. They provide research and development services to the federal government through contract and grant awards focused on advancing solutions for medical and public health challenges.

Through a $399,674 Small Business Innovation Research (SBIR) Phase I contract from the National Institutes of Health National Cancer Institute, Inso Biosciences is performing research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and CDC mission to develop medical solutions that advance public health. The contract is set aside for total small business participation.

Inso Biosciences has also provided research and development services for plant genomics sample preparation methods through a $174,709 USDA National Institute of Food and Agriculture grant. Additionally, they have performed work to develop a culture-free direct-from-sputum method for removing host cells and DNA from clinical tuberculosis samples, enabling more rapid and cost-effective whole-genome sequencing for improved drug susceptibility screening. This $752,682 project grant was awarded by the NIH National Institute of Allergy and Infectious Diseases. Lastly, Inso Biosciences was awarded a $250,000 National Science Foundation SBIR Phase I grant to develop microfluidic technology for single cell multi-omic sample preparation.

Quick answers

What is Inso Biosciences Inc.'s UEI?

Inso Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is VBDURZTP43R3.

What are Inso Biosciences Inc.'s CAGE codes?

Inso Biosciences Inc.'s CAGE codes are 9HVL4 and 84KC0.

What is Inso Biosciences Inc.'s primary NAICS code?

Inso Biosciences Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Inso Biosciences Inc. located?

Inso Biosciences Inc.'s physical address in SAM.gov is Weill Hall, 237 Tower Rd Rm 410, Ithaca, NY 14853, USA.

Is Inso Biosciences Inc. registered in SAM.gov?

Yes. Inso Biosciences Inc.'s SAM.gov registration is active through July 7, 2027.

What is Inso Biosciences Inc.'s most recent federal award?

Inso Biosciences Inc.'s most recent federal grant award is **awards issued prior to january 20, 2025, were funded under previous administrations and may not reflect the priorities… (20233353039281), from Institute of Food Production and Sustainability, on July 1, 2023.

On GovTribe

See Inso Biosciences Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors